AVEO Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 07, 2022 at 04:09 pm EST
AVEO Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 30.45 million compared to USD 15.17 million a year ago. Net loss was USD 3.27 million compared to USD 10.37 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.3 a year ago. Diluted loss per share from continuing operations was USD 0.09 compared to USD 0.3 a year ago.
For the nine months, revenue was USD 76.67 million compared to USD 24.65 million a year ago. Net loss was USD 21.78 million compared to USD 46.09 million a year ago. Basic loss per share from continuing operations was USD 0.63 compared to USD 1.44 a year ago. Diluted loss per share from continuing operations was USD 0.63 compared to USD 1.44 a year ago.